June 2025

Litigation Summary and Analysis for Supernus Pharmaceuticals, Inc. v. Appco Pharma LLC | 1:25-cv-00807 Introduction Supernus Pharmaceuticals, Inc. filed a […]

Introduction: Understanding the Evolving Role of Pharmacy Benefit Managers Pharmacy Benefit Managers (PBMs) are third-party companies that operate as intermediaries

In today’s competitive pharmaceutical landscape, the ability to accurately predict generic drug launches represents a critical strategic advantage for both

Patent filings represent one of the most valuable yet underutilized sources of competitive intelligence in the pharmaceutical industry. By systematically

The pharmaceutical market in the United States functions as a regulated trade-off between the necessity of innovation and the demand

In today’s competitive pharmaceutical landscape, Contract Development and Manufacturing Organizations (CDMOs) must leverage every available advantage to attract and retain

The pharmaceutical industry operates in a complex landscape where strategic intelligence can mean the difference between market leadership and obsolescence.

Executive Summary: The Economics of Loss of Exclusivity In the pharmaceutical sector, the transition from patent exclusivity to generic or

In life-science law, a single trial listing can set off a stampede. When a biotech company quietly logs a Phase